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Multiple sclerosis is characterized by repeated demyelinating attacks of the central nervous system (CNS) white matter tracts.
To tailor novel therapeutics to halt or reverse disease process, we require a better understanding of oligodendrocyte biology
and of the molecular mechanisms that initiate myelination. Cell extrinsic mechanisms regulate CNS myelination through the
interaction of extracellular matrix proteins and their transmembrane receptors. The engagement of one such receptor family,
the integrins, initiates intracellular signaling cascades that lead to changes in cell phenotype. Oligodendrocytes express a diverse
array of integrins, and the expression of these receptors is developmentally regulated. Integrin-mediated signaling is crucial to the
proliferation, survival, and maturation of oligodendrocytes through the activation of downstream signaling pathways involved in
cytoskeletal remodeling.Here,wereview thecurrent understandingofthisimportantsignalingaxis anditsrolein oligodendrocyte
biology and ultimately in the myelination of axons within the CNS.
1.Introduction
Multiple sclerosis (MS) is an inﬂammatory disease of the
CNS resulting in physical and cognitive disabilities. Repeated
attackstothemyelinsheathresultinitsdegeneration[1],and
over time, these demyelinating events leave sclerotic plaques
that are resistant to remyelination. Oligodendrocytes are the
myelin-producing cells of the CNS, providing the insulation
of axons that facilitates eﬃcient saltatory conduction of
action potentials down the neuron.
Oligodendrocytes originate from neuroepithelial cells as
oligodendrocyte precursor cells (OPCs) from the subven-
tricular region of the embryonic brain and ventral spinal
cord [2] .O P C sh a v es i m p l em o r p h o l o g yr e l a t i v et ot h e i r
diﬀerentiated state, bearing only a few processes. These cells
are highly responsive to soluble growth factors (GFs), which
promotes their proliferation/survival [3]. As OPCs mature,
they begin to extend a complex meshwork of processes
with the goal of contacting multiple axons. Once axo-
glial contact has been established, oligodendrocytes produce
large amounts of specialized membrane (myelin) that form
multiple wraps around the contacted axons. The ﬁnal stages
of myelination involve the expulsion of cytoplasm from the
membrane wraps to form compact myelin. The molecular
events underlying oligodendrocyte proliferation, survival,
and maturation are poorly understood, yet knowledge of
these processes is of great value for the development of
therapeutics for demyelinating diseases like MS.
Several signaling pathways have been implicated in the
sequence of molecular events leading to oligodendrocyte-
mediated myelination. It is clear that functional interac-
tion between integrins expressed by oligodendrocytes and
laminin expressed on the cell surface of the neurons they
support is essential for proper myelination to occur. Much
research has been directed towards the integrin family of
receptors and their impact on various aspects of oligoden-
drocyte biology. Oligodendrocytes express a speciﬁc set of
developmentally regulated integrin receptors. Integrins are
responsible for mediating a connection between the extra-
cellular matrix (ECM) and actin cytoskeleton, thus relaying2 Journal of Signal Transduction
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Figure 1: Representation of integrin receptor expression over
the course of oligodendrocyte development. Oligodendrocytes
originate as precursor cells with simple morphology and subse-
quently diﬀerentiate into pro-oligodendrocytes, characterized by
extension of intricate process meshworks. The ﬁnal stages of
maturation involve wrapping of axons in multiple layers of myelin
membrane. Integrin receptors are diﬀerentially expressed during
oligodendrocyte maturation. αvβ1-integrin and α6β1-integrin are
strongly expressed in the oligodendrocyte precursor phase, whereas
αvβ5-integrin is strongly expressed in late stages of development.
αvβ8 is principally expressed in early and late stages of oligoden-
drocyte maturation, while αvβ3-integrin is expressed strongly in
intermediate stages.
signals between both compartments to govern various
cellular processes. Speciﬁcally, integrin signaling has been
linked to GF-mediated survival and proliferation of oligo-
dendrocytes. Integrin-based ampliﬁcation of GF-signaling
depends on common proliferation/survival pathways involv-
ingphosphoinositide3-kinase(PI3K)andmitogen-activated
protein kinase (MAPK) cascades. PI3Ks are a family of ubiq-
uitously expressed proteins responsible for a broad variety of
cellular functions including signal transduction, migration,
proliferation, survival, and cytoskeletal reorganization [4].
Likewise, MAPKs are a group of signaling proteins which
form part of a signaling cascade regulating diverse functions
such as diﬀerentiation, proliferation, and apoptosis [5].
Oligodendrocyte diﬀerentiation and maturation are also
impacted by integrin signaling, involving proteins such as
Fyn kinase. In response to integrin engagement, Fyn kinase
activates various downstream signaling pathways, including
small GTPases such as Cdc42, Rac1, and Rho. Known for
their roles in cytoskeletal remodeling, these small GTPases
respond to integrin signaling to govern the morphological
changes of oligodendrocytes. The goal of the present paper
is to outline the importance of integrin signaling in various
aspects of oligodendrocyte biology.
2. Oligodendrocyte Expression of Integrins
Accumulating evidence suggests that ECM proteins regulate
variousaspectsofoligodendrocytebiology.Speciﬁcally,ECM
constituents such as ﬁbronectin (FN), vitronectin (VN), and
laminin-2 (LN2) have been associated with oligodendrocyte
proliferation, survival, and development [6–18]. These ECM
proteins bind to integrin family members, and mediate
cellular adhesion and bidirectional signaling between the
cellular interior and the external environment. Integrin
receptors are heterodimeric structures composed of α and β
subunits.Eightβsubunitsalongwith18αsubunitshavebeen
discovered,withoneαsubunitpartneringwithoneβsubunit
to form the 24 known integrin heterodimer receptors [19].
The α subunits are believed to specify integrin complexes to
speciﬁc ECM components. For example, α6-integrin tends
to specify the β1 subunit to laminins, whereas αv subunits
specify integrins to RGD-containing ligands such as FN and
VN [19]. Oligodendrocytes express αv subunit complexed
withβ subunits 1,3, 5, and8 [20,21].Thesecellsalsoexpress
the α6 subunit, however they do not express α subunits 1–5
[20].
Expression of integrins is developmentally regulated, and
diﬀerentcelltypesexpressdiversearraysofintegrinsdepend-
ing on their stage of diﬀerentiation. Oligodendrocytes are
no exception, variably expressing α and β subunits based on
developmental stage (Figure 1). For example, αvβ8-integrin
is expressed strongly by precursor and mature oligoden-
drocytes, whereas αvβ3-integrin is expressed predominantly
during intermediate maturity stages [21]. Newly formed
oligodendrocytes strongly express α6β1-integrin, whereas
αvβ5 expression increases as oligodendrocytes mature [20,
22, 23].
The expression pattern of integrins by oligodendrocytes
is not only developmentally regulated, but is aﬀected by the
natureofthesurroundingenvironment.ChangesintheECM
constituents are reﬂected by alterations in oligodendrocyte
integrin expression. For example, when oligodendrocyte-
like cells derived from hippocampal neural progenitors are
seeded on LN2, β1-integrin expression is increased with
respect to cells seeded on non-LN2 substrates [24]. The
presence of cultured neurons also appears to inﬂuence the
expression proﬁle of OL integrin receptors. Milner et al.
[21] observed that the decrease in expression of αvβ8-
integrin in isolated oligodendrocytes during intermediate
stages of development is less pronounced when cocultured
with neurons.
The above studies highlight the dynamic nature of
integrin expression by oligodendrocytes and allow for
further questioning the roles played by integrin receptors
in oligodendrocyte biology. Generally, integrins mediate
diverse cellular functions of oligodendrocytes, especially
proliferation, survival, diﬀerentiation, and maturation.
3. Proliferation and Survivalof
Oligodendrocytes
During maturation, oligodendrocytes experience increased
expression of proapopotic molecules, whereas antiapoptotic
protein activity remains unchanged [25]. Oligodendro-
cytes are thus especially susceptible to programmed cell
death during development, highlighting the importance of
extracellular cues for promoting their proliferation/survival.
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have demonstrated roles for both PI3K and MAPK pathways
in various aspects of oligodendrocyte biology [26, 27]. More
recently, these pathways appear to be impacted by integrins,
mediated through their interaction with ECM molecules.
Integrin ligation by ECM proteins appears to be a key
factor in the proliferation and survival of oligodendro-
cytes. In parallel, trophic factors such as platelet-derived
growth factor (PDGF) and neuregulin-1 (NRG) also support
oligodendrocyte proliferation and survival [28]. Recently,
integrins and GF receptors (GFRs) have been shown to
cooperate in a fashion to promote proliferation and survival
in response to various ECM and trophic signals. These
signals are subsequently relayed to downstream signaling
molecules such as PI3K and MAPK, principally via Src
family kinases (SFKs). To fully understand the regulation
of oligodendrocyte proliferation and survival, the relation-
ship between integrin ligation and GF reception must be
explored. The following sections will cover some key studies
highlighting advances in the knowledge of integrin signaling
in oligodendrocyte proliferation and survival.
3.1. Integrin Activation Sensitizes GF Signaling. The impor-
tance of integrin receptors in oligodendrocyte proliferation
and survival is evidenced by a number of studies involving
genetic manipulation of integrin receptor subunits. For
example, the expression of a dominant-negative β1-integrin
in oligodendrocytes causes a region-speciﬁc depletion of
mature (CC1+) oligodendrocytes in certain CNS regions,
followed by alterations in MAPK activity [29]. β1-integrin
subunit blocking also dramatically decreases oligodendro-
cyte survival [7], and deletion of the β1-integrin gene in
murine oligodendrocytes leads to oligodendroglial apoptosis
within the embryonic brainstem [30]. α6-integrins also play
a role in proliferation/survival, since α6-integrin null mice
have increased apoptosis of newly formed oligodendrocytes
[10]. This work indicates a clear role for integrin receptors
in oligodendrocyte survival, and the mechanism governing
integrin-enhanced survival is thought to involve facilitation
of GF signaling.
While integrin-based adhesion in itself does not pro-
mote oligodendrocyte survival, integrin ligation with ECM
substrates inﬂuences GFR-based survival signaling. This
phenomenon has been observed in a number of stud-
ies, where the α6β1-integrin substrate, LN2, increases the
sensitivity of oligodendrocytes to soluble PDGF thereby
facilitating survival [7, 10, 17, 31, 32]. The α6β1-integrin is
the only laminin receptor of the integrin family expressed
by oligodendrocytes [20] suggesting that α6β1-integrin is
responsible for LN2-mediated enhancement GF survival
signaling. Expression of chimeric α-integrin subunits in
oligodendrocytes further supports this hypothesis [10].
Under normal conditions, the α6β1-integrin receptor binds
LN2, while the integrin α5-containing receptors preferen-
tially bind FN. In the latter study, the extracellular and
transmembrane domains of α5-integrin were fused with
the cytoplasmic tail of the α6-integrin subunit. Expression
of this hybrid α5/α6-integrin subunit in oligodendrocytes
increased survival during concurrent FN adhesion and
PDGFadministration, a response normallyobserved onLN2
substrate via α6β1-integrin receptors. These results indicate
that the survival-promoting events occurring via concurrent
LN2 ligation and PDGF administration are mediated via
α6β1-integrin receptors. While this study demonstrates a
relationship between integrin and PDGF signaling, it does
not explain how integrins and GFRs (such as PDGFR-α)
interact. More recent research has aimed to determine the
mechanism by which integrins interact with other receptor
types to promote oligodendrocyte proliferation and survival
[9, 10, 13, 17, 33].
3.2. Integrins and GFR Interactions. How does the coop-
eration between integrins and GFRs promote survival in
oligodendrocytes? A leading hypothesis suggests that GFRs
and integrin receptors are recruited to one another during
concurrent integrin and GFR ligation. In light of this
hypothesis, αvβ3-integrin has been described to physically
interact with PDGFR-α in oligodendrocytes grown on VN
(αvβ3-integrin ligand), and in the presence of PDGF [9].
Oligodendrocyte proliferation under these conditions is
perturbedbyblockingthePI3KandPKCsignalingpathways,
suggesting αvβ3/PDGFR-α signaling is dependant on this
pathway. A similar result was obtained by Colognato et al.
[12], where αvβ3-integrin-enhanced PDGF oligodendrocyte
signaling was impaired with knockdown of the SFK family
member Fyn.
Oligodendrocyte integrin receptors also modulate sig-
naling by GFs other than PDGF, such as neuregulin-1
(NRG) [10, 12, 28, 34]. NRG is a soluble GF with a role
in oligodendrocyte proliferation and survival [28]. NRG is
predominantly expressed on the neuronal surface and acts as
a survival and proliferative cue for oligodendrocytes through
ErbB receptors [34]. On non-laminin substrates, NRG
application to oligodendrocytes induces their proliferation
via the PI3K pathway (Figure 2(a)[i]) [10]. Under these
conditions, oligodendrocytes are sensitive to wortmannin
treatmentandthusdependonthePI3Kpathwayforsurvival.
Once oligodendrocytes are seeded on LN2 (α6β1-integrin
ligand), they lose their sensitivity to wortmannin, indicating
an altered function of NRG. On LN2 rather, NRG activates
the MAPK survival pathway (Figure 2(a)[ii]), as evidenced
by increased phosphorylation (and thus inactivation) of the
apoptotic protein BAD. Also, knockdown of SFK member
Fyn prevents LN2-induced switching of the PI3K/MAPK
pathways in response to soluble NRG [12]. These studies
suggest that α6β1-integrin ligation mediates a switch in the
function of NRG; without LN2 binding, NRG promotes
a proliferative signal via PI3K. Conversely, upon LN2
adhesion, NRG no longer promotes proliferation but rather
promotes diﬀerentiation/survival via MAPK, and Fyn is
required for this signaling transition. Since certain laminin
subunits are expressed on axons of the CNS [35–37],
integrin-mediated adhesion of oligodendrocytes to axonal
laminins may amplify NRG signaling via Fyn to promote
diﬀerentiation/survival over proliferation. This enhanced
survival is speciﬁcally mediated by α6β1-integrin and is
alsoobservedduringoligodendrocytecontactwithastrocytic
laminins [38].4 Journal of Signal Transduction
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Figure 2: Integrins interact with other receptor types to mediate oligodendrocyte survival and proliferation. (a) Cooperative signaling
betweenErbBandintegrinreceptors.BindingofNRGtooligodendrocyteErbBreceptorsnormallyevokesaproliferativeresponsedependant
on PI3K signaling. Upon α6β1-integrin ligation with LN2, NRG binding no longer induces PI3K activation, but rather initiates the
MAPK survival response via Fyn signaling. (b) Joint regulatory control of survival in response to cooperative contactin and integrin
receptor signaling. LN2 ligation of α6β1-integrin causes the dephosphorylation of Fyn’s negative regulatory site Tyr531. L1 binding to the
contactinreceptorinducesthephosphorylationofTyr420(activationsite)andTyr531.Integrationofextracellularcuesviacontactin/integrin
crosstalk facilitates the dynamic control of Fyn to execute cellular functions aﬀecting survival. (c) PDGFR-a and α6β1-integrin interact in
oligodendrocyte lipid rafts. PI3K and Akt are activated upon concurrent ligation of PDGFR-α and α6β1-integrin with PDGF and LN2,
respectively, to promote proliferation/survival.Journal of Signal Transduction 5
Integrin receptors may also interact with non-GFRs to
mediate adhesion-based survival enhancement. In a recent
report from Laursen et al. [17], oligodendrocyte α6β1-
integrins were shown to physically interact with the non-
GF receptor contactin. Contactin is the receptor for the
axonally expressed L1 ligand [39, 40]a n dm a yp l a yar o l e
in myelination. As previously observed, oligodendrocytes
grown on LN2 showed a dose-dependant increase in survival
in response to physiological doses of PDGF. This eﬀect was
also observed when cells were grown on non-LN2 substrates
in the presence of L1-Fc and PDGF. Culturing of cells on
LN2 with L1-Fc and PDGF proved to have an additive eﬀect
to promote survival, suggesting a synergistic relationship
between integrin, contactin and PDGFR-α signaling. This
cooperative signaling in response to ligation inﬂuences the
phosphorylation state of Fyn kinase. Fyn may be phospho-
rylated at Tyr420 (activation site) or at Tyr531 (inhibitory
site), which allows for dynamic dual regulatory control of
Fyn activity [41]. Upon binding LN2, α6β1-integrin ligation
causes the dephosphorylation of Tyr531, while contactin/L1
binding increased phosphorylation of both Tyr531 and
Tyr420 sites [17]. Ligation with either LN2 or L1 partially
enhanced survival, whereas copresentation of both ligands
further intensiﬁed the potential for survival. This provides
jointregulatorycontrolofoligodendrocytesurvivalsignaling
via Fyn in response to the axonal surface and surrounding
ECM (Figure 2(b)). In order for these signaling events
to occur eﬃciently, there must be coordination between
individual proteins within the integrin signaling pathway.
In oligodendrocytes, this compartmentalization of signaling
cascades likely involves lipid rafts.
3.3. Lipid Rafts Stabilize GFR and Integrins. Lipid rafts are
membrane structures composed of embedded lipoproteins
and signaling molecules such as Fyn [42]. These structures
are more organized than the typical bilayer, but are free
ﬂoating within it. They tend to contain more cholesterol and
have increased levels of glycosphingolipids such as sphin-
gomyelin [43, 44]. Lipid rafts ensure that signaling cascade
constituents are within appropriate molecular distance to
facilitate signal transduction by raft-bound receptors [45].
During development, oligodendrocytes extend mem-
brane sheets eventually forming myelin, facilitating neural
transmission. The biochemistry of these specialized mem-
brane sheets must be critical for their function, likely
requiringlipidraft-mediatedsignalingformyelinbiogenesis.
In oligodendrocytes, integrins rely on PI3K and Akt for
the transduction of ECM-derived signals. PI3K recruitment
to lipid rafts occurs during growth of oligodendrocytes on
LN2, a known α6β1-integrin ligand [13]. α6β1-integrin also
localizes to oligodendrocyte lipid rafts, and raft disruption
via chemical means perturbs PI3K-dependant α6β1-integrin
mediated survival. Blocking of the β1-integrin subunit also
depletes phosphorylated Akt within rafts. Therefore, α6β1-
integrin receptors are localized within oligodendrocyte lipid
rafts, and activate downstream signaling proteins to enhance
survival in response to LN2 ligation. Integrin function
is important in oligodendrocyte lipid rafts, but how do
integrins interact with GFRs within these structures to
amplify survival signaling?
For eﬃcient interaction between integrins and GFRs to
occur, it is fair to assume that they must be located/recruited
within close proximity to each other. Research has suggested
that the mechanism underlying GFR/integrin cooperative
signaling is facilitated by colocalization of these receptors
within lipid rafts as shown by Baron et al. [33]. In this study,
PDGFR-α localized to oligodendrocyte lipid rafts. Baron
[33] also demonstrated oligodendrocyte growth on LN2
substrate with soluble PDGF recruits PDGFR-α to α6β1-
integrin rich rafts, and α6β1-integrin/PDGFR-α clustering
acceleratedthephosphorylationofAktandPI3Kwithinlipid
rafts (Figure 2(c)).
Similar phenomena occur in other cell systems such
as keratinocytes, where clustering of α6β4-integrin with
epidermal growth factor receptor is required for GF-
dependant proliferation via SFK signaling [46]. In terms of
oligodendrocytes, cooperative signaling between lipid raft-
localized integrins and PDGFR-α inﬂuence PI3K and Akt
signaling which are important for proliferation and survival.
Of equal importance are the signaling cascades underlying
oligodendrocyte diﬀerentiation and myelination, processes
also governed by the integrins.
4. Differentiation andMyelination
Integrin receptors are important for the normal morpho-
logical development of oligodendrocytes in vitro,a n df o r
their myelinating function in vivo. Of the various integrin
receptors expressed by oligodendrocytes, the α6β1-integrin
is the only known integrin complex that binds LN2 [19,
20]. Since many axonal tracts of the CNS express laminins,
it is reasonable to hypothesize that α6β1-integrin plays
an important role in myelination [35–37]. Speciﬁcally, it
appears the β1 subunit of the α6β1 receptor is especially
crucial for oligodendrocyte maturation; β1-integrin relays
signals from the ECM to downstream signaling proteins
ultimately impacting on development. Intracellular proteins
that have been recently associated with β1-integrin signaling
include integrin linked kinase (ILK), focal adhesion kinase
(FAK), Akt, Fyn, Rac1, Cdc42, and Rho. These proteins are
largelyinvolvedincytoskeletalremodelingandthereforemay
play an important role in the morphological development of
oligodendrocytes in response to β1-integrin activation.
4.1. β1-Integrin in Oligodendrocyte Development. The inﬂu-
enceofintegrinsonoligodendrocytedevelopmentisthought
to be governed by ECM components in axonal tracts [10].
Disruption of ECM-integrin connection results in a variety
of developmental defects, including aberrant process and
myelin sheet formation, along with delayed expression of
myelin proteins. In contrast, integrin ligation facilitates
the normal development of oligodendrocytes, as illustrated
by work showing that oligodendroglial membranes are
enhanced upon constitutive integrin activation [47]. Mem-
brane extension in vitro appears to be largely impacted
by β1-integrin ligation. Antibody blocking of β1-integrin6 Journal of Signal Transduction
reduces the ability of oligodendrocytes to extend processes
in vitro, leading to a less arborous morphology as compared
to control-treated cells [6]. Parallel results replicated by
several other groups highlight the importance of β1-integrin
signaling in normal oligodendrocyte development [14, 32,
48]. Even perturbation of the β1-integrin binding partner
ILK is suﬃcient to cause oligodendrocyte morphological
defects [11].
The question of how β1-integrin impacts oligodendro-
cyte function in vivo is a topic of recent debate [29–32, 48,
49]. The controversy may be caused by a combination of
three main factors; the alternate methods used to disrupt
β1-integrin, the varying promoters used to elicit β1-integrin
perturbation and/or the existence of non-integrin type
receptors with a role in myelination. Firstly, studies use
diﬀerent promoters to drive the ablation/mutant overexpres-
sion of β1-integrin. The use of alternative promoters may
aﬀect the speciﬁcity of expression to oligodendrocytes, as
well may vary the developmental time during which this
expression is incurred. Benninger et al. [30]o b s e r v e dn o
obvious defects in CNS myelination when β1-integrin was
ablated in oligodendrocytes under the 2,3-cyclic nucleotide
3-phosphodiesterase (CNP) promoter. CNP is expressed
during later stages of oligodendrocyte development [50],
therefore use of this promoter may preclude expression
during early oligodendrocyte diﬀerentiation. Perhaps β1-
integrin expression during these early stages is crucial for the
initiation of myelination, and ablation ensuing this critical
window may produce no overt myelin defect. To address
this possibility, Barros et al. [32] used a nestin promoter-
driven Cre recombinase to ablate β1-integrin. Nestin is
expressed in neurons and glia of the CNS, thus, use of this
promoter would ablate β1-integrin early in oligodendrocyte
development [51]. In this study, abnormal myelination was
observed in the optic nerve, cerebellum, and spinal cord
[32], emphasizing the importance of promoter choice when
perturbing β1-integrin.
The second possible explanation for the controversy sur-
rounding the importance of β1-integrin in CNS myelination
involves the contrasting means of disrupting β1-integrin
among studies (i.e., various dominant-negative constructs
versus complete ablation). However, it is important to
remember that this second possibility remains a function of
the promoter used to drive mutant expression. Early work
demonstrated a reduced ability of dominant-negative β1-
integrin expressing oligodendrocytes to remyelinate axons in
acutely demyelinated rodent nerve tracts [48]. Myelination
defects were also seen when Lee et al. [29] overexpressed
a dominant negative version of β1-integrin lacking the
C-terminal cytoplasmic tail under the proteolipid protein
(PLP) promoter. The latter group observed hypomyelination
in the spinal cord and optic nerves, which is in contrast
to the study by Benninger et al. [30], who used complete
ablation over the dominant-negative approach. The diﬀering
results may be explained by the alternative means used to
disrupt β1-integrin (i.e., dominant-negative versus knock-
out), or, as mentioned above, the diﬀerent promoters used
to drive the mutation (PLP versus CNP). This highlights
the importance for a consensus on which promoter to use
when driving mutation expression in oligodendrocytes, and
whichdominant-negative/knockoutmodeltotakeadvantage
of when disrupting β1-integrin.
The third possible source of discrepancy may be
explainedbytheexistenceofanothertypeofoligodendrocyte
laminin receptor with a role in myelination. α6β1-integrin
is the only known laminin receptor of the integrin family
expressed by oligodendrocytes [20]. Of interest, the dys-
troglycan receptor has been recently identiﬁed as a second
laminin receptor with a role in CNS myelination. Depletion
of dystroglycan causes a reduced ability of oligodendrocytes
to form myelinated segments on neurons in an oligo-
dendrocyte/neuron coculture [31]. In fact, β1-integrin and
dystroglycan have overlapping laminin binding regions and
thus may compete for this ligand in vivo [52, 53]. Since
the dominant-negative β1-integrin used by Lee et al. [29]i s
hypothesized to retain laminin binding, Cˆ amara et al. [49]
argues these mutant integrin receptors may compete with
dystroglycan for the laminin ligand. This would result in an
apparent mutant β1-integrin-mediated reduction of myelin
thickness. However, the underlying cause of the hypomyeli-
nation may be due to fewer occupied dystroglycan receptors,
which are required for myelin maintenance [31]. To resolve
the possible competitive eﬀect, Cˆ amara et al. [49] expressed
a chimeric β1-integrin subunit consisting only of its cyto-
plasmic tail speciﬁcally in oligodendrocytes. This dominant-
negative β1-integrin should be unable to form laminin
receptors when bound to α subunits, thus eliminating
possible competition withdystroglycan. While theyobserved
no overt myelination defects upon expression of this mutant
β1-integrin receptor, closerexamination revealed thatlarger-
diameter axons were preferentially myelinated over smaller-
diameter axons. In this report, Cˆ amara et al. [49] discusses
possible mechanisms on how this may occur. First, oligo-
dendrocytes in small-caliber axon tracts are required to
extend more processes than oligodendrocytes in large axon
ﬁber tracts, since more axons exist per cross-sectional area
in small-caliber axon tracts. Since β1-integrin perturbation
hinders process extension, this debility would prevent oligo-
dendrocytes from extending membrane to contact neighbor-
ing axons. This defect in axo-glial contact would be exacer-
batedinregionsofsmall-caliberaxonsduetothelargernum-
ber of axons with respect to large-caliber axon tracts [49].
Another possible reason for the reduced myelination of
small axons upon β1-integrin perturbation involves trophic
signaling [49]. LN2 has a promyelinating inﬂuence on
oligodendrocytes, which is mediated through β1-integrin.
This promyelinating eﬀect is proportional to axonal caliber.
Therefore, the increased amount of promyelinating LN2
ligand on large-caliber axons may allow for β1-integrin
deﬁcient oligodendrocytes to overcome the defects seen in
regions of smaller-caliber axons [49].
Based on the evidence presented in the above-mentioned
studies, perturbation of β1-integrin results in abnormal CNS
myelination under certain conditions. More recent work
aims to determine which downstream signaling proteins
may underlie the defects observed in β1-integrin deﬁcient
oligodendrocytes. Culminating evidence implicates signaling
proteins such as Fyn, Akt, FAK, and small GTPases.Journal of Signal Transduction 7
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Figure 3: The inﬂuence of α6β1-integrin signaling on oligo-
dendrocyte morphology. Signaling proteins FAK and Akt are
phosphorylated upon LN2-mediated activation of α6β1-integrin.
Similarly,Fynisactivatedviaα6β1-integrinbindingtoLN2,thereby
activating the cytoskeletal remodeling proteins Rho, Cdc42, and
Rac1. The activation of FAK, Akt, Rho, Cdc42, and Rac1 by α6β1-
integrin signaling impacts on oligodendrocyte process extension
and is likely implicated in oligodendrocyte development. Solid and
dashed lines, respectively, represent direct and indirect interactions.
4.2. Integrin Inﬂuence on Cytoskeletal Remodeling Proteins.
Integrin activation via extracellular ligands has been inves-
tigated in a wide variety of cell types, and is known to result
in recruitment of signaling proteins to focal adhesion sites.
FAK and Akt are two such proteins and have been extensively
studied with regards to their roles in oligodendrocyte
biology and myelination [15, 18, 54–61]. These integrin-
associated proteins are believed to transduce signals from the
cytoplasmic domain of β1-integrin. FAK is a protein tyrosine
kinase involved in cellular adherence and spreading, whereas
Akt is a serine/threonine protein kinase, and its activity
promotes cellular survival (Figure 3). Although it is not clear
whether FAK or Akt directly interacts with β1-integrin in
oligodendrocytes, evidence suggests they are activated by
integrins within focal adhesions [33, 62–64]. Speciﬁcally,
the Tyr397 residue of FAK undergoes autophosphorylation
during integrin ligation by ECM components [65]. This
occurs in oligodendrocytes, where phosphorylation of FAK
at various tyrosine residues (including Tyr397) is enhanced
when cells are seeded on LN2 substrate [15]. Similarly,
Akt phosphorylation within α6β1-integrin rich lipid rafts is
increased in response to concurrent LN2 ligation and PDGF
administration [33]. Increased FAK and Akt activation in
response to LN2 binding suggests β1-integrin mediates this
signaling process. Since early in vitro work demonstrates
oligodendrocyte morphological defects upon depletion of
β1-integrin [6, 14, 32, 48], does altered expression of FAK
and Akt impact on oligodendrocyte development?
In fact, knockdown of FAK prevents oligodendrocyte
process extension in response to LN2 adhesion [15, 18]. This
LN2-speciﬁc developmental defect upon knockdown of FAK
reinforces the notion that β1-integrin signaling in maturing
oligodendrocytes is required for normal morphological
development. Process extension defects are also seen in
oligodendrocytes where Akt signaling is perturbed. Upon
depletion of β1-integrin in oligodendrocytes, Akt activity
is consequently reduced. The resultant reduction in Akt
activity likely underlies the developmental defects observed
in these β1-integrin deﬁcient oligodendrocytes [32]. This
hypothesis is further supported by Flores et al. [57]a n d
Narayanan et al. [60]. Upon expression of constitutively
active Akt, the CNS is hypermyelinated [57, 60] suggesting
that overstimulation of the Akt signaling pathway produces
overdevelopment of oligodendrocytes, the opposite of what
is seen upon reduction of Akt activity.
Interestingly, conditional knockout of FAK during the
onset of myelination results in a reduction in the number
of myelinated axons [59]. This is compensated for at later
time points, but regardless, both FAK and Akt appear to
be important players in transducing ECM signals via β1-
integrin to contribute to oligodendrocyte development.
Other studies have implicated Fyn in integrin sig-
naling, ultimately aﬀecting oligodendrocyte development.
In contrast to FAK and Akt, Fyn is known to directly
associate with α6β1-integrin in oligodendrocytes under
various GF and substrate conditions [12, 42]. Early work
showed oligodendrocyte precursors express Fyn, and Fyn’s
expression increases as oligodendrocytes mature [42, 66].
Both pharmacological inhibition and mutagenesis studies
demonstrate a requirement for Fyn in membrane sheet
formation in primary oligodendrocytes [66]. In addition
to morphological defects upon Fyn knockdown, Colognato
et al. [12] reported a reduction in MBP-expressing cells,
suggesting the expression of crucial myelin proteins is
also dependant on Fyn activity. The presence of LN2 also
highly aﬀects Fyn’s activity, and in laminin-deﬁcient mice
(dy/dy) there is an increase in the phosphorylation of Fyn’s
negative regulatory site (Tyr531). The above studies lend
evidence to a linear signal cascade initiated by α6β1-integrin
ligation by LN2, and subsequent signal transduction via Fyn
to activate downstream signaling proteins. Thus, it is of
interest to determine which proteins Fyn is eﬀectuating to
ensurenormaloligodendrocytedevelopment.Recently,small
GTP asessuchasCdc42,Rac1,andRhoappeartoprovidethis
role.
Cdc42, Rac1, and Rho are GTPases expressed by oligo-
dendrocytes [14, 67], among other cell types. GTPases are
considered active when bound to GTP, and inactive when
GDP-bound. GTP-bound Cdc42 and Rac1 build ﬁlamentous
actin while GTP-bound Rho depolymerizes actin ﬁlaments,
thus, these proteins impact on cell morphology. Integrin
signaling has proven to play a role in GTPase-mediated
oligodendrocytemorphologicaldiﬀerentiation.Forexample,
F y na c t i v a t i o nv i aα6β1-integrin ligation inﬂuences the
activity of Rac1, Cdc42, and Rho (Figure 3). Wang et al.
[68] showed that depletion of activated Fyn in oligoden-
drocytes depletes GTP-bound Rac1, GTP-bound Cdc42, and8 Journal of Signal Transduction
GDP-bound Rho. Consequently, this altered GTPase activity
accompanied morphological defects, oﬀering an importance
for these proteins in oligodendroglial process extension
[68]. In addition, Fyn phosphorylates RhoGAPs, which are
responsible for modulating the GDP-bound state of Rho.
Fyn phosphorylates p190RhoGAP, and this phosphorylation
event increases with oligodendrocyte diﬀerentiation [69].
The activity of Rho heavily inﬂuences oligodendrocyte
development, since studies using dominant-negative Rho
(mimics GDP-bound state) reported hyperextension of
oligodendrocyte processes [69].
Liang et al. [14] provided more evidence showing that
C d c 4 2a n dR a c 1a r ea c t i v a t e db yF y ni naβ1-integrin-
dependant manner. This group made use of various exper-
imental paradigms to show that β1-integrin inﬂuences
the phosphorylation state of Fyn, ultimately impacting
oligodendrocyte morphology via Cdc42 and Rac1 activity.
Oligodendrocyte process extension was reduced when cells
were treated with β1-integrin blocking antibodies, as well as
kinase dead or non-palmitoylable/myristoylable Fyn. These
Fyn constructs either possessed no kinase activity (kinase
dead) or were unable to localize to the plasma membrane
(non-palmitoylable/myristoylable), where Fyn is theorized
to be activated. The application of β1-integrin blocking
antibodies also directly reduced Fyn’s activity as measured by
autophosphorylation assays, and prevented the activation of
Cdc42 and Rac1 [14]. The importance of these GTPases in
myelination was further evidenced by Thurnherr et al. [70]
who speciﬁcally ablated Cdc42 or Rac1 in oligodendrocytes
in vivo. Ablation of either Cdc42 or Rac1 resulted in
aberrantmyelinoutfoldings,whereasthedoubleCdc42/Rac1
knockout exacerbated this phenotype. Therefore, Cdc42 and
Rac1 likely work synergistically to modulate similar eﬀectors
of a common pathway to mediate myelin sheath formation.
From the above studies, a number of conclusions can
be drawn. First, it is clear that β1-integrin ligation by LN2
inﬂuences the activity states of FAK and Akt. This change
in activity of FAK and Akt impacts on oligodendroglial
diﬀerentiation as evidenced by altered capacity to extend
processes. Second, Fyn is directly activated by ligated β1-
integrins, and Fyn inﬂuences the activity state of Cdc42 and
Rac1 (Figure 3). Once activated by Fyn, these proteins mod-
ulate actin dynamics, ultimately governing oligodendrocyte
morphology. Misregulation of the aforementioned signaling
proteins results in aberrant oligodendrocyte development
both in vitro and in vivo. Therefore, β1-integrin signaling to
downstreameﬀectorsisrequiredfornormaloligodendrocyte
development.
4.3. Integrin Inﬂuence on CNS Remyelination. The involve-
ment of the ECM and integrin signaling cascades in oligo-
dendrocytedevelopmentandmyelinationraisesthequestion
of whether these systems play a role in remyelination of
the CNS after demyelination is induced in diseases such
as MS. Demyelination is characterized by the progressive
loss of myelin surrounding axons, negatively impacting on
propagation of neuronal impulses. Demyelinated lesions
can be remyelinated by adult OPCs; however, over time
sclerotic plaques become resistant to this process. While
the cause of remyelination resistance is unknown, it is
likely not due to a lack of ECM molecules required for
oligodendrocyte-mediated remyelination. Evidence support-
ing this possibility is provided by Satoh et al. [71], who
conducted proteome proﬁling on postmortem sclerotic
lesions obtained from MS patients. This analysis indicated
an enrichment of integrin, focal adhesion, and ECM-related
proteins in various types of MS plaques. In parallel, using
animal demyelination/remyelination models, some studies
demonstrate an increased deposition of ECM constituents
following demyelination of white matter tracts. Of interest,
Zhao et al. [72] observed increased LN2 expression in axonal
tracts during formation of new myelin sheaths following
ethidium bromide-induced demyelination. This is similar to
the observation of ECM molecules on demyelinated axon
processes within MS-patient derived plaques [73]. These
studies suggest that ECM ligands necessary for integrin-
mediated remyelination are present in demyelinated lesions,
but they do not address whether the interaction of oligo-
dendrocyte integrins with these ligands is important for
remyelination.
Relvas et al. [48] demonstrated an importance for
oligodendrocyte β1-integrin in the remyelination of rodent
spinal cords. This group transplanted OPCs expressing a
dominant-negative β1-integrin construct into demyelinated
spinal cord lesions. Relative to OPCs expressing a vector
control, the OPCs expressing the dominant-negative β1-
integrin were unable to remyelinate an equivalent number
of axons over a three week period [48]. In a cuprizone
demyelination paradigm, Lee et al. [29]d e m o n s t r a t e da
decrease in total number of remyelinated axons in the corpus
callosum of mice expressing an oligodendrocyte-speciﬁc
dominant-negative β1-integrin. Additionally, the α-integrin
subunit has also been shown to play a role in remyelination.
Subsequent to toxin-induced focal demyelination of the rat
caudal cerebellar peduncle, there is an upregulation of αv-
integrin in OPCs within the lesion site [72].
It is apparent that ECM molecules are expressed in
lesions following demyelination, and integrin function plays
a role in the remyelination process. The obvious question is,
why do plaques become resistant to remyelination following
repeated demyelination? The failure of sclerotic plaques to
remyelinate over time may be due to the accumulation
of myelin debris within the plaques themselves. Myelin
debris inhibits the diﬀerentiation of OPCs, thereby ren-
dering the plaques resistant to remyelination. Research has
shown that modulation of downstream proteins involved in
integrin signaling potentiates the diﬀerentiation of OPCs,
even in these remyelination-resistant conditions. Speciﬁcally,
manipulation of the Fyn-RhoA-ROCK signaling cascade,
through the use of pharmacological or siRNA-mediated
inhibition of RhoA-ROCK-II, enhances OPC diﬀerentiation
in the presence of myelin debris [74]. This is of interest since
Fyndirectlyassociateswithα6β1-integrin[12],andsignaling
from integrins through Fyn modulates oligodendrocyte
developmentviaRhofamilyGTPases[14].Therefore,myelin
debris may inhibit normal functioning of integrin signaling
pathways required for remyelination. This ﬁnding revealsJournal of Signal Transduction 9
potential targets for drug development aimed at treating
demyelinating diseases.
The above studies implicate the ECM, the integrins, and
their downstream pathways in oligodendrocyte-mediated
remyelination of white matter tracts. This knowledge will
no doubt play an important role in the development of
therapeuticsforthetreatmentofdemyelinatingdiseasessuch
as MS.
5. Conclusion
Axonal tracts provide an environment rich in molecular cues
likely inﬂuencing the fate of oligodendrocytes. Speciﬁcally,
integrin ligation by ECM proteins within axonal tracts can
impact oligodendrocyte biology. A speciﬁc array of integrin
receptors is expressed by oligodendrocytes, and expression
may be modulated by extracellular cues. Integrins play a
role in the proliferation/survival of oligodendrocytes, as
evidenced by reduced survival upon integrin perturbation.
Oligodendrocytes experience increased sensitivity to GFs
upon ligation of α6β1-integrin. In some cases, presence
of ECM constituents allows the physical interaction of
GFRs and α6β1-integrin, especially in lipid rafts. This
interaction between the ECM, integrin receptors, and GFRs
mediates oligodendrocyte survival and diﬀerentiation with
dependence on the PI3K and MAPK signaling pathways.
α6β1-integrin receptors may also interact with non-GFRs to
result in parallel cellular responses.
Fyn kinase underlies many of the proliferation/survival
eﬀects via integrins in oligodendrocytes, and the same holds
true during diﬀerentiation, and myelination. β1-integrin
plays a signiﬁcant role in the normal development of
oligodendrocytes,anddependsonspeciﬁcproteins forsignal
transductionfromtheECMtothecellularinterior.Inpartic-
ular,FAK,AktandFynareactivatedbyβ1-integrins,andmay
interact with other signaling proteins such as small GTPases.
According to the literature highlighted in this paper,
integrinsplayamajorroleinthebiologyofoligodendrocytes.
Perhaps in the near future, molecular manipulation of the
integrin signaling pathway in oligodendrocytes in a clinical
setting will allow cessation of MS disease progression and
even promote remyelination of sclerotic plaques.
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